ReviewFrontiers in medicine2014
Update on Molecular Pathology of Cutaneous Melanocytic Lesions: What is New in Diagnosis and Molecular Testing for Treatment?
Review in Frontiers in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysis.Orphanet journal of rare diseases · 2022Pooled it
- Discordance Between Morphology and Molecular Findings in Dermatopathology: A Perspective on Diagnostic Integration.Journal of cutaneous pathology · 2026Article
- Rare Lacrimal Gland Melanoma: A Case Report and Treatment Insights.The American journal of case reports · 2025Article
- A 13-Year-Old Girl Affected by Melanocytic Tumors of the Central Nervous System-The Case.International journal of molecular sciences · 2024Article
- Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2018Review
- CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases.Virchows Archiv : an international journal of pathology · 2018Article
- The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response.Oncotarget · 2016Article
- Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.Pathology · 2016Review
- Next-generation sequencing: advances and applications in cancer diagnosis.OncoTargets and therapy · 2016Review
- Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects.Brain pathology (Zurich, Switzerland) · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, we give an update on recent findings regarding molecular pathology in cutaneous melanocytic tumors. The focus lies on use of genetics in the diagnosis of distinct subtypes of spitzoid tumors that are often characterized by specific phenotypic-genotypic alterations that can frequently be recognized by adequate histological examination. Typical illustrating cases are given in order to increase recognition of these lesions in daily dermatopathology practice. New molecular findings in the pathogenesis of congenital melanocytic tumors and neurocutaneous melanosis are reviewed. In addition, use of mutation analysis in the differential diagnosis of melanoma metastasis is discussed. Finally, application of mutation analysis in targeted therapy in advanced melanoma with advantages of new techniques such as next generation sequencing is described.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.